Related references
Note: Only part of the references are listed.RAFT polymerization to form stimuli-responsive polymers
Graeme Moad
POLYMER CHEMISTRY (2017)
Neutrophils: Their Role in Innate and Adaptive Immunity 2017
Carlos Rosales et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia et al.
NPJ VACCINES (2017)
Dendritic cell targeted vaccines: Recent progresses and challenges
Pengfei Chen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Liposomal Texaphyrin Theranostics for Metastatic Liver Cancer
Min Hee Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines
Cecilia Buonsanti et al.
SCIENTIFIC REPORTS (2016)
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
Christophe Macri et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
The March Toward Malaria Vaccines
Stephen L. Hoffman et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2015)
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
Geoffrey M. Lynn et al.
NATURE BIOTECHNOLOGY (2015)
Class-switched memory B cells remodel BCRs within secondary germinal centers
Louise J. McHeyzer-Williams et al.
NATURE IMMUNOLOGY (2015)
Enhanced Humoral Responses Induced by Targeting of Antigen to Murine Dendritic Cells
L. H. Pugholm et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
Gaps in knowledge and prospects for research of adjuvanted vaccines
Robert Seder et al.
VACCINE (2015)
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Angela D. Pardee et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine
Li-Zhen He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle et al.
CHEMMEDCHEM (2013)
Anti-viral CD8 T cells and the cytokines that they love
Maureen A. Cox et al.
VIROLOGY (2013)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization
Satwinder Kaur Singh et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity
Takemasa Tsuji et al.
JOURNAL OF IMMUNOLOGY (2011)
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
James J. Moon et al.
NATURE MATERIALS (2011)
Targeting TLRs Expands the Antibody Repertoire in Response to a Malaria Vaccine
Steven R. Wiley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
Joe Cohen et al.
HUMAN VACCINES (2010)
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
Sachiko Hirosue et al.
VACCINE (2010)
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
Kavita Tewari et al.
VACCINE (2010)
Mechanism of action of clinically approved adjuvants
Bart N. Lambrecht et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate
Matthew L. Plassmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?
Grant R. Campbell et al.
RETROVIROLOGY (2009)
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity
Silayuv E. Bongfen et al.
VACCINE (2009)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
O-glycosylated human MUC1 repeats are processed in vitro by immunoproteasomes
Tanja Ninkovic et al.
JOURNAL OF IMMUNOLOGY (2007)
Th1 and Th2 cells help CD8 T-cell responses
Melinda J. Ekkens et al.
INFECTION AND IMMUNITY (2007)
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation
Sven Burgdorf et al.
SCIENCE (2007)
Cooperation of Toll-like receptor signals in innate immune defence
Giorgio Trinchieri et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging
Jun Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
BSA degradation under acidic conditions: A model for protein instability during release from PLGA delivery systems
Tia Estey et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE®)
J Alexander et al.
VACCINE (2004)
Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity
O Silvie et al.
NATURE MEDICINE (2003)
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
H Hemmi et al.
NATURE IMMUNOLOGY (2002)
C-type lectin receptors on dendritic cells and Langerhans cells
CG Figdor et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Imiquimod and resiquimod as novel immunomodulators
DH Dockrell et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)